These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4829385)

  • 1. Editorial: The FDA and the pharmacist as an advisor on nonprescription drugs.
    Zellmer WA
    Am J Hosp Pharm; 1974 May; 31(5):447. PubMed ID: 4829385
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA OTC advisory group needs practitioners.
    Jellin JM
    Am Pharm; 1993 Apr; NS33(4):4, 90. PubMed ID: 8475854
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Dr. Jekyll and Mr. Hyde.
    Feldmann EG
    J Pharm Sci; 1974 Mar; 63(3):1. PubMed ID: 4820358
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacists' evaluations of the nonprescription availability of metaproterenol, cimetidine, ibuprofen, and nystatin.
    Madhavan S; Schondelmeyer SW
    Am J Hosp Pharm; 1989 Dec; 46(12):2486-92. PubMed ID: 2603883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA proposes banning 258 nonprescription drug ingredients.
    Clin Pharm; 1990 Aug; 9(8):598. PubMed ID: 2387129
    [No Abstract]   [Full Text] [Related]  

  • 6. The FDA takes action against unapproved drugs.
    Meadows M
    FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA bans 223 ingredients in nonprescription drug products.
    Clin Pharm; 1991 Feb; 10(2):88, 93. PubMed ID: 2009736
    [No Abstract]   [Full Text] [Related]  

  • 8. OTC labeling reform.
    J Am Pharm Assoc (Wash); 1997; NS37(6):619-20. PubMed ID: 9425787
    [No Abstract]   [Full Text] [Related]  

  • 9. Advisory committees; OTC Drugs Advisory Committee; establishment--FDA. Final rule.
    Fed Regist; 1991 Sep; 56(185):48103-4. PubMed ID: 10114368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe & sound. Interview by Helena Gail Rubinstein.
    Woodcock J
    AHIP Cover; 2009; 50(2):38-43. PubMed ID: 19385317
    [No Abstract]   [Full Text] [Related]  

  • 11. Is three a crowd or company?: Behind-the-counter drugs.
    Barth AS
    Food Drug Law J; 2008; 63(4):865-89. PubMed ID: 19601386
    [No Abstract]   [Full Text] [Related]  

  • 12. Panel recommends limits on alcohol content of nonprescription products. FDA Over-The-Counter Drugs Advisory Committee.
    Am J Hosp Pharm; 1993 Mar; 50(3):400. PubMed ID: 8442445
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorials: The FDA--reprise.
    Thomison JB
    J Tenn Med Assoc; 1973 Nov; 66(11):1071-2. PubMed ID: 4756263
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: To cough or not to cough.
    J Am Osteopath Assoc; 1973 Dec; 73(4):268-70. PubMed ID: 4491950
    [No Abstract]   [Full Text] [Related]  

  • 15. No doctor required. The FDA may expand the number of prescription drugs it converts to over-the-counter use.
    Thompson M
    Time; 2000 Jul; 156(3):38. PubMed ID: 11009720
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA considers OTC drug labeling reform.
    Am Pharm; 1995 Nov; NS35(11):5-6. PubMed ID: 8533722
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: Harmless, but ineffective, remedies.
    Feldmann EG
    J Pharm Sci; 1975 Oct; 64(10):I. PubMed ID: 1185526
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA considers implementing behind-the-counter system.
    Sipkoff M
    Manag Care; 2008 May; 17(5):17-8. PubMed ID: 18567463
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: Safe and sane use of OTC's.
    Tice LF
    Am J Pharm Sci Support Public Health; 1973; 145(6):187-8. PubMed ID: 4768815
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA panel vetoes OTC version of cholesterol drug.
    Walczak IM
    Diabetes Technol Ther; 2000; 2(3):484. PubMed ID: 11467353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.